These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus. Ikeda T; Iwata K; Tanaka Y Diabetes Res Clin Pract; 1999 Mar; 43(3):193-8. PubMed ID: 10369429 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of aldose reductase inhibitors for diabetic gastroenteropathy with constipation. Nakamura T; Okano R; Uchiyama H; Seo Y; Okuda S Intern Med; 1997 Jul; 36(7):479-83. PubMed ID: 9240496 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. Nagamachi S; Fujita S; Nishii R; Futami S; Tamura S; Mizuta M; Nakazato M; Kurose T; Wakamatsu H J Nucl Cardiol; 2006; 13(1):34-42. PubMed ID: 16464715 [TBL] [Abstract][Full Text] [Related]
11. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043 [TBL] [Abstract][Full Text] [Related]
12. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats. Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532 [TBL] [Abstract][Full Text] [Related]
13. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement]. Shimada H; Miki T; Kyogoku I; Kawagishi T; Inaba M; Okuno Y; Nishizawa Y; Morii H No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304 [TBL] [Abstract][Full Text] [Related]
14. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Schnell O; Kirsch CM; Stemplinger J; Haslbeck M; Standl E Diabetologia; 1995 Nov; 38(11):1345-52. PubMed ID: 8582545 [TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H Jpn Circ J; 1995 Sep; 59(9):599-607. PubMed ID: 7500543 [TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. Nakayama M; Nakamura J; Hamada Y; Chaya S; Mizubayashi R; Yasuda Y; Kamiya H; Koh N; Hotta N Diabetes Care; 2001 Jun; 24(6):1093-8. PubMed ID: 11375376 [TBL] [Abstract][Full Text] [Related]
17. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Okamoto H; Nomura M; Nakaya Y; Uehara K; Saito K; Kimura M; Chikamori K; Ito S Intern Med; 2003 Aug; 42(8):655-64. PubMed ID: 12924487 [TBL] [Abstract][Full Text] [Related]
18. I-123 metaiodobenzylguanidine imaging in non-insulin-dependent diabetic patients with normal myocardial perfusion scans: new insights into their increased cardiac morbidity and mortality rates. Mushtaq N; Gerson MC J Nucl Cardiol; 2006; 13(1):8-10. PubMed ID: 16464711 [No Abstract] [Full Text] [Related]
19. Evaluation of the cardiac autonomic nervous system in spontaneously non-insulin-dependent diabetic rats by 123I-metaiodobenzylguanidine imaging. Togane Y Ann Nucl Med; 1999 Feb; 13(1):19-26. PubMed ID: 10202944 [TBL] [Abstract][Full Text] [Related]
20. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Hongo M; Urushibata K; Kai R; Takahashi W; Koizumi T; Uchikawa S; Imamura H; Kinoshita O; Owa M; Fujii T Am Heart J; 2002 Jul; 144(1):122-9. PubMed ID: 12094198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]